Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

ClinicalTrials.gov ID: NCT05455606

Public ClinicalTrials.gov record NCT05455606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Cluster Randomized Trial Comparing an Educationally Enhanced Genomic Tumor Board (EGTB) Intervention to Usual Practice to Increase Evidence-Based Genome-Informed Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This clinical trial studies how well an educationally enhanced genomic tumor board (EGTB) intervention works to increase the number of patients with solid tumors that have come back (recurrent), do not respond to treatment (refractory), have spread to other parts of the body (metastatic), or are newly diagnosed and spread to other parts of the body (advanced) who receive genome-informed treatment. Genome-informed treatment refers to treatment based on the information found in genomic tumor test results. This study compares the usual approach to reviewing genomic tumor test results with the approach of having a genomic tumor board (GTB) review the test results. A GTB is team of doctors and scientists that have experience in understanding genomic changes and review genomic tumor test results. The tumor board helps to suggest whether there are other cancer treatment options based on patient genetic test results. The usual approach is to review genomic tumor test results without the GTB being involved. This study may help researchers learn if using a GTB enhances the treatment decision making process within 6 months of joining the study. This study may also help researchers learn if using the GTB increases doctors' understanding of genomic tumor test results and increases doctors' comfort level with genomic tumor tests.

Study identification

NCT ID
NCT05455606
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
1,284 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 14, 2022 (Actual)
Primary completion
Dec 15, 2026 (Estimated)
Completion
Mar 1, 2027 (Estimated)
Last update posted
Jan 22, 2026

2022 – 2027

United States locations

U.S. sites
70
U.S. states
16
U.S. cities
63
Facility City State ZIP Site status
Cancer Center at Saint Joseph's Phoenix Arizona 85004 —
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah Georgia 31405 —
Hawaii Cancer Care Inc - Waterfront Plaza Honolulu Hawaii 96813 —
Queen's Medical Center Honolulu Hawaii 96813 —
Straub Clinic and Hospital Honolulu Hawaii 96813 —
University of Hawaii Cancer Center Honolulu Hawaii 96813 —
Kapiolani Medical Center for Women and Children Honolulu Hawaii 96826 —
Hawaii Cancer Care - Westridge ‘Aiea Hawaii 96701 —
Pali Momi Medical Center ‘Aiea Hawaii 96701 —
Kootenai Clinic Cancer Services - Post Falls Post Falls Idaho 83854 —
Illinois CancerCare-Bloomington Bloomington Illinois 61704 —
Illinois CancerCare-Canton Canton Illinois 61520 —
Carle at The Riverfront Danville Illinois 61832 —
Illinois CancerCare-Galesburg Galesburg Illinois 61401 —
Carle Physician Group-Mattoon/Charleston Mattoon Illinois 61938 —
Illinois CancerCare-Ottawa Clinic Ottawa Illinois 61350 —
Illinois CancerCare-Peoria Peoria Illinois 61615 —
Carle Cancer Center Urbana Illinois 61801 —
Iowa Methodist Medical Center Des Moines Iowa 50309 —
Medical Oncology and Hematology Associates-Des Moines Des Moines Iowa 50309 —
HaysMed University of Kansas Health System Hays Kansas 67601 —
Lawrence Memorial Hospital Lawrence Kansas 66044 —
Olathe Health Cancer Center Olathe Kansas 66061 —
University of Kansas Cancer Center-Overland Park Overland Park Kansas 66210 —
Salina Regional Health Center Salina Kansas 67401 —
University of Kansas Health System Saint Francis Campus Topeka Kansas 66606 —
Saint Joseph Hospital East Lexington Kentucky 40509 —
Saint Joseph London London Kentucky 40741 —
Saint Joseph Mercy Hospital Ann Arbor Michigan 48106 —
Saint Joseph Mercy Brighton Brighton Michigan 48114 —
Saint Joseph Mercy Chelsea Chelsea Michigan 48118 —
Ascension Saint John Hospital Detroit Michigan 48236 —
Trinity Health Saint Mary Mercy Livonia Hospital Livonia Michigan 48154 —
Saint Joseph Mercy Oakland Pontiac Michigan 48341 —
Essentia Health Saint Joseph's Medical Center Brainerd Minnesota 56401 —
Minnesota Oncology - Burnsville Burnsville Minnesota 55337 —
Mercy Hospital Coon Rapids Minnesota 55433 —
Essentia Health Cancer Center Duluth Minnesota 55805 —
Unity Hospital Fridley Minnesota 55432 —
Saint John's Hospital - Healtheast Maplewood Minnesota 55109 —
New Ulm Medical Center New Ulm Minnesota 56073 —
Park Nicollet Clinic - Saint Louis Park Saint Louis Park Minnesota 55416 —
Regions Hospital Saint Paul Minnesota 55101 —
Lakeview Hospital Stillwater Minnesota 55082 —
Ridgeview Medical Center Waconia Minnesota 55387 —
Minnesota Oncology Hematology PA-Woodbury Woodbury Minnesota 55125 —
Fairview Lakes Medical Center Wyoming Minnesota 55092 —
Parkland Health Center - Farmington Farmington Missouri 63640 —
Truman Medical Centers Kansas City Missouri 64108 —
University of Kansas Cancer Center - North Kansas City Missouri 64154 —
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 —
University of Kansas Cancer Center at North Kansas City Hospital North Kansas City Missouri 64116 —
Delbert Day Cancer Institute at PCRMC Rolla Missouri 65401 —
Sainte Genevieve County Memorial Hospital Sainte Genevieve Missouri 63670 —
CoxHealth South Hospital Springfield Missouri 65807 —
Missouri Baptist Medical Center St Louis Missouri 63131 —
Missouri Baptist Sullivan Hospital Sullivan Missouri 63080 —
Missouri Baptist Outpatient Center-Sunset Hills Sunset Hills Missouri 63127 —
FirstHealth of the Carolinas-Moore Regional Hospital Pinehurst North Carolina 28374 —
Essentia Health Cancer Center-South University Clinic Fargo North Dakota 58103 —
Lehigh Valley Hospital-Cedar Crest Allentown Pennsylvania 18103 —
Saint Joseph's/Candler - Bluffton Campus Bluffton South Carolina 29910 —
Gibbs Cancer Center-Gaffney Gaffney South Carolina 29341 —
Gibbs Cancer Center-Pelham Greer South Carolina 29651 —
Spartanburg Medical Center Spartanburg South Carolina 29303 —
MGC Hematology Oncology-Union Union South Carolina 29379 —
Ascension Southeast Wisconsin Hospital - Elmbrook Campus Brookfield Wisconsin 53045 —
Ascension Saint Francis - Reiman Cancer Center Franklin Wisconsin 53132 —
Ascension Columbia Saint Mary's Hospital Ozaukee Mequon Wisconsin 53097 —
Ascension Medical Group Southeast Wisconsin - Mayfair Road Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05455606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05455606 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →